OCUL logo

OCUL Ocular Therapeutix, Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$6.21
-0.07 (-1.11%)

Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage …

Market Cap: $1.37Bwww.ocutx.com

Price

No data yet.

Social Signal Score

48
5d
50
1 mentions
—
30d
48
6 mentions
—
60d
48
8 mentions
—
90d
46
9 mentions
—
news: 9

Analyst Ratings

19 analysts
Buyconsensus
Strong Buy 1Buy 16Hold 2Sell 0Strong Sell 0
Avg price target$23+270.4%
Low $14Median $25High $30
Current Consensus

Revenue

$12.87M+2419.37%
$340.0K$5.92M$11.50M$17.08M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-1.45
$-1.51–$-1.35
5 analysts
FY2026
$-1.59
$-1.63–$-1.55
6 analysts
FY2027
$-1.64
$-1.96–$-1.07
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Pravin U. Dugel
Sector
Healthcare
Industry
Biotechnology
Employees
325
Beta
0.99
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
1.07
www.ocutx.com